Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Design Therapeutics, Inc. (DSGN) had Weighted-Average Shares Outstanding (Diluted) of 56.59M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-49.59M |
|
-- |
|
-- |
|
$62.38M |
|
$-62.38M |
|
$12.79M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-49.59M |
|
$-62.38M |
|
$-67.98M |
|
56.59M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
56.59M |
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$248.04M |
|
$1.41M |
|
$4.05M |
|
$252.09M |
|
$8.46M |
|
-- |
|
$1.53M |
|
$10.00M |
|
$242.10M |
|
$242.10M |
|
$242.10M |
|
56.75M |
|
| Cash Flow Statement Financials | |
$-43.10M |
|
$43.95M |
|
$0.51M |
|
$21.20M |
|
$22.56M |
|
$1.36M |
|
$13.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
29.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.48% |
|
-20.48% |
|
-19.67% |
|
-20.48% |
|
$4.27 |
|
$-0.77 |
|
$-0.76 |
|